Users Coming Off Slimming Injections Gain Back Weight Four Times Faster Compared to People Using Diet and Exercise

New research reveals that people who discontinue blockbuster weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass far faster than those who halt conventional diet and exercise programs.

Published data in a prominent health publication shows that while overweight individuals frequently drop a large proportion of their body weight while using the jabs, the weight comes back at an estimated rate of nearly a kilo each month upon discontinuation.

"Individuals buying these treatments must be aware of the potential of fast rebound weight gain when the treatment is stopped," warns lead investigator Dr. Susan Jebb.

Such speed of regain implies a return to starting weight in about 18 months.

Weighing Therapies

The analysis, which examined dozens of trials involving thousands of participants, contrasted the effects of these new drugs with other pills.

The team point out that people who lose weight through diet and exercise usually see a less rapid creep back—perhaps 100 grams monthly—once they finish.

The Reason for the Fast Rebound

Nutrition scientists believe the way of the injections is key to understanding the accelerated regain.

The injections mimic a natural hormone called GLP-1, which moderates appetite.

"Long-term administration of GLP-1 levels several times higher than the body's typical production could lead to the system to generate a reduced amount of its endogenous hormone, and may also diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition researcher.

"Stopping of this GLP-1 'fix' results in hunger is uncontrolled, making excessive eating a significant risk."

A Lifelong Issue?

The NHS recommend the jabs for individuals with obesity-related health risks, accompanied by prescribed lifestyle changes.

A number of clinicians contend that, given the significant potential of relapse, the treatment is often long-term.

This view is echoed by pharmaceutical companies, who say that the findings "highlight the persistent nature of obesity," similar to managing diseases like hypertension.

User Testimonies

People who have come off the medication describe a intense resurgence of cravings.

"It was like a switch that goes on and you're instantly ravenous," said one woman.

This difficulty is exacerbated if users have not adopted permanent dietary or behavioural changes during treatment.

Growing Use

Recent estimates show that millions of adults in the UK have tried these injections in the last 12 months, with desire being substantial.

• Use is higher among females compared to males.
• The middle-aged age group shows the greatest level of interest.
• A large proportion obtain the medications through private prescriptions rather than public health services.

In conclusion, researchers caution that while these medications are effective tools for weight loss, they are not a magic solution and long-term success relies on combined behavioural support.